Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,309 | -5,540 | -3,897 | -2,511 | -1,160 |
| Depreciation Amortization | 74 | 213 | 148 | 96 | 47 |
| Accounts receivable | -76 | -71 | 5 | -58 | -11 |
| Other Working Capital | 145 | 412 | -70 | 57 | 86 |
| Other Operating Activity | 2,637 | -456 | -113 | -40 | 136 |
| Operating Cash Flow | $-1,530 | $-5,443 | $-3,926 | $-2,456 | $-901 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -192 | -14 | -13 | -3 | N/A |
| Other Investing Activity | 0 | -168 | 0 | 0 | 0 |
| Investing Cash Flow | $-192 | $-182 | $-13 | $-3 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -9 | N/A | N/A | N/A |
| Common Stock Issued | 1,029 | 23,783 | 6,954 | 6,340 | 4,587 |
| Other Financing Activity | 144 | 879 | 18,086 | 17,654 | 342 |
| Financing Cash Flow | $1,173 | $24,652 | $25,040 | $23,994 | $4,929 |
| Beginning Cash Position | 22,001 | 3,141 | 3,213 | 3,139 | 3,069 |
| End Cash Position | 21,451 | 22,168 | 24,314 | 24,674 | 7,097 |
| Net Cash Flow | $-550 | $19,027 | $21,101 | $21,535 | $4,027 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,530 | -5,443 | -3,926 | -2,456 | -901 |
| Capital Expenditure | -192 | -14 | -13 | -3 | N/A |
| Free Cash Flow | -1,722 | -5,457 | -3,939 | -2,458 | -901 |